000 01258 a2200337 4500
005 20250515111929.0
264 0 _c20081022
008 200810s 0 0 eng d
022 _a0278-5846
024 7 _a10.1016/j.pnpbp.2008.01.006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBrietzke, Elisa
245 0 0 _aTNF-alpha as a molecular target in bipolar disorder.
_h[electronic resource]
260 _bProgress in neuro-psychopharmacology & biological psychiatry
_cAug 2008
300 _a1355-61 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntimanic Agents
_xpharmacology
650 0 4 _aApoptosis
_xphysiology
650 0 4 _aBipolar Disorder
_xdrug therapy
650 0 4 _aCell Survival
_xphysiology
650 0 4 _aCognition Disorders
_xgenetics
650 0 4 _aCytokines
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMood Disorders
_xmetabolism
650 0 4 _aNF-kappa B
_xgenetics
650 0 4 _aTumor Necrosis Factor-alpha
_xbiosynthesis
700 1 _aKapczinski, Flávio
773 0 _tProgress in neuro-psychopharmacology & biological psychiatry
_gvol. 32
_gno. 6
_gp. 1355-61
856 4 0 _uhttps://doi.org/10.1016/j.pnpbp.2008.01.006
_zAvailable from publisher's website
999 _c17818998
_d17818998